Abstract OT2-14-01: Pyrotinib after trastuzumab-based adjuvant therapy in high-risk early human epidermal growth factor receptor 2-positive breast cancer: a multicenter phase 2 tri... by Cao, Feilin, Ma, Zhaosheng, Hu, Guinv, Zhu, Xiaotao, Li, Shuguang, Chen, Shuzheng, Chen, Binglie, Li, Zhanwen, Wu, Weizhu, Ji, Xiaochun, Shu, Jingde, Tao, Deyou, Hu, Xiaoqing, Zheng, Min, Wang, Ouchen, Feng, Qingjing, Hao, Jing, Li, Xujun

Get full text